HDAC7 is a key factor for the germinal center reaction and its underexpression is associated with DLBCL prognosis


Por: Meler, A, Gusi-Vives, M, de Barrios, O, Azagra, A, Collazo, O, Melchor, J, Del Monte-Monge, A, Gyorffy, B, Verdu-Bou, M, Navarro, JT, Martín-Subero, JI, Roué, G, Ramiro, AR, Roa, S and Parra, M

Publicada: 1 mar 2026
Resumen:
Histone deacetylase HDAC7 is required for early B cell development and governs the acquisition of B cell progenitors gene identity. Its role in mature B cell biology and associated malignancies is unknown. Here, by using a conditional mouse model for specific deletion in activated B cells, we demonstrate that HDAC7 is essential for the formation of germinal centers (GC). HDAC7 deficiency results in the generation of aberrant GCB cells, diminished class switch recombination (CSR) and plasma cell (PC) formation. We demonstrate that low expression of HDAC7 in diffuse large B cell lymphoma (DLBCL) tumors is associated with poor prognosis of the patients. Importantly, expression of HDAC7 in DLBCL cell lines reduces the proliferative capacity, as well as DLBCL tumorigenicity in vivo. In summary, our data revealed first, the important function of HDAC7 in the establishment of the GC, and second, the potential contribution of HDAC7 deregulation in DLBCL.

Filiaciones:
Meler, A:
 Josep Carreras Leukaemia Res Inst, Lymphocyte Dev & Dis Grp, Badalona 08916, Spain

:
 Josep Carreras Leukaemia Res Inst, Lymphocyte Dev & Dis Grp, Badalona 08916, Spain

 Univ Barcelona UB, Doctoral Programme Biomed, Barcelona, Spain

:
 Josep Carreras Leukaemia Res Inst, Lymphocyte Dev & Dis Grp, Badalona 08916, Spain

Azagra, A:
 Josep Carreras Leukaemia Res Inst, Lymphocyte Dev & Dis Grp, Badalona 08916, Spain

:
 Josep Carreras Leukaemia Res Inst, Lymphocyte Dev & Dis Grp, Badalona 08916, Spain

Melchor, J:
 Univ Navarra, Dept Biochem & Genet, Pamplona, Spain

Del Monte-Monge, A:
 Ctr Nacl Invest Cardiovasc, Cell Biol Lab B, Madrid, Spain

Gyorffy, B:
 TTK, Canc Biomarker Res Grp, Budapest, Hungary

 Semmelweis Univ, Dept Bioinformat, Budapest, Hungary

 Semmelweis Univ, Dept Pediat, Budapest, Hungary

:
 Josep Carreras Leukaemia Res Inst, Lymphoid Neoplasms Grp, Badalona, Spain

:
 Josep Carreras Leukaemia Res Inst, Lymphoid Neoplasms Grp, Badalona, Spain

 Germans Trias & Pujol Hosp, Inst Catala Oncol, Dept Hematol, Badalona, Spain

 Univ Autonoma Barcelona, Dept Med, Badalona, Spain

Martín-Subero, JI:
 Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain

 Univ Barcelona, Barcelona, Spain

 Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain

:
 Josep Carreras Leukaemia Res Inst, Lymphoma Translat Grp, UBIRed, Badalona, Spain

Ramiro, AR:
 Ctr Nacl Invest Cardiovasc, Cell Biol Lab B, Madrid, Spain

Roa, S:
 Univ Navarra, Dept Biochem & Genet, Pamplona, Spain

:
 Josep Carreras Leukaemia Res Inst, Lymphocyte Dev & Dis Grp, Badalona 08916, Spain
ISSN: 15506606





Journal of Immunology
Editorial
American Association of Immunologists, 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 215 Número: 3
Páginas:
WOS Id: 001716692700001
ID de PubMed: 41847858
imagen hybrid

MÉTRICAS